Código QR (código de barras bidimensional)

Safety and efficacy of anti-CD30 CAR-T cell therapy in relapsed/refractory classic Hodgkin lymphoma: a systematic review and meta-analysis

Abstract Background Relapsed/refractory classic Hodgkin lymphoma (R/R cHL) remains challenging to treat, and anti-CD30 chimeric antigen receptor T (CAR-T) cell therapy may be effective. This meta-analysis investigates the efficacy and safety of anti-CD30 CAR-T cell therapy for treating R/R cHL. Meth...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Principais autores: Fanqiao Meng, Maoyuan Xiang, Yu Liu, Dongfeng Zeng
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2025-01-01
Serier:BMC Cancer
Fag:
Online adgang:https://doi.org/10.1186/s12885-024-13400-5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!